Jay Edelberg

Direttore/Membro del Consiglio presso Prolaio, Inc.

Health Technology

Commercial Services

Consumer Services

Posizioni attive di Jay Edelberg

Società	Posizione	Inizio	Fine
Prolaio, Inc. Prolaio, Inc. BiotechnologyHealth Technology Prolaio, Inc. is a company founded in 2021 that engages in research and development of medical. The company is based in Scottsdale, AZ.	Direttore/Membro del Consiglio	-	-
	Segretario Aziendale	-	-

Società	Posizione	Inizio	Fine
MYOKARDIA, INC.	Direttore Tecnico/Scientifico/R&S	-	01/11/2020
SANOFI	Corporate Officer/Principal	-	-

Duke University

Doctorate Degree

Distribuzione geografica

Stati Uniti	4
Francia	2

Posizioni

Corporate Officer/Principal	1
Chief Tech/Sci/R&D Officer	1
Doctorate Degree	1

Settori

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
SANOFI	Commercial Services

Aziende private	2
MyoKardia, Inc. MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology MyoKardia, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, commercialization, and development of therapies for the treatment of cardiovascular diseases. Its lead therapeutic candidate, Mavacamten, is an orally administered allosteric modulator of cardiac myosin being developed for the treatment of hypertrophic cardiomyopathy (HCM). The company was founded by James A. Spudich, Jonathan G. Seidman, Christine Seidman, and Leslie Leinwand on June 8, 2012 and is headquartered in South San Francisco, CA.	Health Technology
Prolaio, Inc. Prolaio, Inc. BiotechnologyHealth Technology Prolaio, Inc. is a company founded in 2021 that engages in research and development of medical. The company is based in Scottsdale, AZ.	Health Technology

Aziende private

Health Technology